Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation

Nephrology Dialysis Transplantation

Volumn 25, Issue 1, 2010, Pages 17-24

  Reinders, Marlies E J ^a   Fibbe, Willem E ^a   Rabelink, Ton J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Mesenchymal stem cells; Renal disease and transplantation; Repair

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A;

ANGIOGENESIS; CELL ISOLATION; CELL MIGRATION; CELL POPULATION; CELL THERAPY; CELLULAR DISTRIBUTION; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; HAZARD; HUMAN; HYPERGLYCEMIA; IMMUNITY; IN VIVO STUDY; KIDNEY GRAFT REJECTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; RHEUMATOID ARTHRITIS; STROMA CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE REPAIR;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MULTIPOTENT STEM CELLS; STROMAL CELLS;

EID: 72949104337     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp552     Document Type: Review

References (83)

1. Sagrinati C, Ronconi E, Lazzeri E et al. Stem-cell approaches for kidney repair: choosing the right cells. Trends Mol Med 2008; 14: 277-285
2. Reinders ME, Rabelink TJ, Briscoe DM. Angiogenesis and endothe-lial cell repair in renal disease and allograft rejection. J Am Soc Nephrol 2006; 17: 932-942
3. Sagrinati C, Netti GS, Mazzinghi B et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006; 17: 2443-2456
4. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-2213
5. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
6. Horwitz EM, Le Blanc K, Dominici M et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393-395
7. Calvi LM, Adams GB, Weibrecht KW et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-846
8. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008; 8: 290-301
9. Woodbury D, Schwarz EJ, Prockop DJ et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364-370
10. Liu JW, Dunoyer-Geindre S, Serre-Beinier V et al. Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost 2007; 5: 826-834
11. Weng YS, Lin HY, Hsiang YJ et al. The effects of different growth factors on human bone marrow stromal cells differentiating into hepatocyte-like cells. Adv Exp Med Biol 2003; 534: 119-128
12. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317
13. Lazarus HM, Haynesworth SE, Gerson SL et al. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16: 557-564
14. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822
15. Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722-3729
16. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843
17. Stagg J. Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens 2007; 69: 1-9
18. Glennie S, Soeiro I, Dyson PJ et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105: 2821-2827
19. Nauta AJ, Kruisselbrink AB, Lurvink E et al. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 2006; 177: 2080-2087
20. Corcione A, Benvenuto F, Ferretti E et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107: 367-372
21. Ortiz LA, Gambelli F, McBride C et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100: 8407-8411
22. Casiraghi F, Azzollini N, Cassis P et al. Pretransplant infusion of mes-enchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008; 181: 3933-3946
23. Jones S, Horwood N, Cope A et al. The antiproliferative effect of mes-enchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 2007; 179: 2824-2831
24. Krampera M, Cosmi L, Angeli R et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006; 24: 386-398
25. Meisel R, Zibert A, Laryea M et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004; 103: 4619-4621
26. English K, Barry FP, Field-Corbett CP et al. IFN-gamma and TNF-alpha differentially regulate immunomodulationbymurine mesenchy-mal stem cells. Immunol Lett 2007; 110: 91-100
27. Adcock IM, Tsaprouni L, Bhavsar P et al. Epigenetic regulation of airway inflammation. Curr Opin Immunol 2007; 19: 694-700
28. Haniffa MA, Wang XN, Holtick U et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mes-enchymal stem cells. J Immunol 2007; 179: 1595-1604
29. Semedo P, Wang PM, Andreucci TH et al. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplant Proc 2007; 39: 421-423
30. Togel F, Hu Z, Weiss K et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005; 289: F31-42
31. Ninichuk V, Gross O, Segerer S et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 2006; 70: 121-129
32. Mias C, Lairez O, Trouche E et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 2009; [epub ahead of print]
33. Herrera MB, Bussolati B, Bruno S et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004; 14: 1035-1041
34. Imberti B, Morigi M, Tomasoni S et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 2007; 18: 2921-2928
35. Morigi M, Imberti B, Zoja C et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004; 15: 1794-1804
36. Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 2008; 59: 311-325
37. Humphreys BD, Valerius MT, Kobayashi A et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008; 2: 284-291
38. Held PK, Al-Dhalimy M, Willenbring H et al. In vivo genetic selection of renal proximal tubules. Mol Ther 2006; 13: 49-58
39. Prodromidi EI, Poulsom R, Jeffery R et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 2006; 24: 2448-2455
40. Katayama K, Kawano M, Naito I et al. Irradiation prolongs survival of Alport mice. J Am Soc Nephrol 2008; 19: 1692-1700
41. Rabelink TJ, Wijewickrama DC, de Koning EJ. Peritubular endothe-lium: the Achilles heel of the kidney?. Kidney Int 2007; 72: 926-930
42. Chen J, Park HC, Addabbo F et al. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int 2008; 74: 879-889
43. Morigi M,Introna M, Imberti B et al. Human bone marrow mesenchy-mal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26: 2075-2082
44. Hung SC, Pochampally RR, Chen SC et al. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007; 25: 2363-2370
45. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31
46. Reinders ME, Sho M, Izawa A et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity.J Clin Invest 2003; 112: 1655-1665
47. Zacharek A, Chen J, Cui X et al. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab 2007; 27: 1684-1691
48. Morrison SJ, Spradling AC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008; 132: 598-611
49. Arai F, Hirao A, Ohmura M et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-161
50. Mias C, Trouche E, Seguelas MH et al. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 2008; 26: 1749-1757
51. Ittrich H, Lange C, Togel F et al. In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T. J Magn Reson Imaging 2007; 25: 1179-1191
52. Fox JM, Chamberlain G, Ashton BA et al. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 2007; 137: 491-502
53. Togel F, Isaac J, Hu Z et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67: 1772-1784
54. Burton CJ, Combe C, Walls J et al. Secretion of chemokines and cytokines by human tubular epithelial cells in response to proteins. Nephrol Dial Transplant 1999; 14: 2628-2633
55. Herrera MB, Bussolati B, Bruno S et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007; 72: 430-441
56. Schrepfer S, Deuse T, Reichenspurner H et al. Stem cell transplantation: the lung barrier. Transplant Proc 2007; 39: 573-576
57. Behr L, Hekmati M, Fromont G et al. Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postis-chemic kidney. Nephron Physiol 2007; 107: p65-76
58. Kunter U, Rong S, Djuric Z et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephri-tis. J Am Soc Nephrol 2006; 17: 2202-2212
59. Kunter U, Rong S, Boor P et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomeru-lar adipocytes. J Am Soc Nephrol 2007; 18: 1754-1764
60. Guillot PV, Cook HT, Pusey CD et al. Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J Pathol 2008; 214: 627-636
61. Lee RH, Seo MJ, Reger RL et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 2006; 103: 17438-17443
62. Zhang W, Qin C, Zhou ZM. Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model. Transplant Proc 2007; 39: 3404-3408
63. Tse WT, Pendleton JD, Beyer WM et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389-397
64. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441
65. Inoue S, Popp FC, Koehl GE et al. Immunomodulatory effects of mes-enchymal stem cells in a rat organ transplant model. Transplantation 2006; 81: 1589-1595
66. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-48
67. Zhou HP, Yi DH, Yu SQ et al. Administration of donor-derived mes-enchymal stem cells can prolong the survival of rat cardiac allograft. Transplant Proc 2006; 38: 3046-3051
68. Nauta AJ, Westerhuis G, Kruisselbrink AB et al. Donor-derived mes-enchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006; 108: 2114-2120
69. Garcia-Olmo D, Garcia-Arranz M, Herreros D et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005; 48: 1416-1423
70. Ringden O, Uzunel M, Sundberg B et al. Tissue repair using al-logeneic mesenchymal stem cells for hemorrhagic cystitis, pneu-momediastinum and perforated colon. Leukemia 2007; 21: 2271-2276
71. Bang OY, Lee JS, Lee PH et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57: 874-882
72. Chen S, Liu Z, Tian N et al. Intracoronary transplantation of autolo-gous bone marrow mesenchymal stem cells for ischemic cardiomyopa-thy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol 2006; 18: 552-556
73. Katritsis DG, Sotiropoulou PA, Karvouni E et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc In-terv 2005; 65: 321-329
74. Koc ON, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215-222
75. Lazarus HM, Koc ON, Devine SM et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389-398
76. Lee ST, Jang JH, Cheong JW et al. Treatment of high-risk acute myel-ogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol 2002; 118: 1128-1131
77. Vojtassak J, Danisovic L, Kubes M et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro En-docrinol Lett 2006; 27: 134-137
78. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313
79. Le Blanc K, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262: 509-525 (Pubitemid 47620502)
80. Studeny M, Marini FC, Champlin RE et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002; 62: 3603-3608
81. Karnoub AE, Dash AB, Vo AP et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-563
82. Bernardo ME, Zaffaroni N, Novara F et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007; 67: 9142-9149
83. Mannello F, Tonti GA. Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement noncondi-tioned medium, or ad hoc formula? All that glitters is not gold!. Stem Cells 2007; 25: 1603-1609